Welcome to Medications.com
Positive Results from Phase III Trial of Gamunex(R) in Patients ... - Business Wire (press release)
The primary endpoint, response in functional disability, was observed in 54 percent of subjects treated with Gamunex (2g/kg loading dose, followed by 1g/kg ...
http://www.businesswire.com/porta... |
Posted: Thu Feb 07 09:14:57 -0500 2008
Gamunex RSS Feed
© 2002-2007, Skylabs Inc. |
About Us |
Disclaimer/Terms of Use |
Advertise |
Contact Us |
Site Map |
Developed by:
W3matter.com |
Sleep Apnea
